The Follicular Lymphoma Foundation (FLF) CURE FL Awards
Organizations and individual applicants can apply.
Opens Jan 10 2022 12:00 AM (EST)
Deadline Apr 15 2022 11:59 PM (EDT)
Description


The Follicular Lymphoma Foundation (FLF) CURE FL Awards

Curative Research to Eliminate Follicular Lymphoma

Letters of Intent due February 4, 2022 | Full Proposals due April 15, 2022


Follicular lymphoma, a blood cancer that affects the lymph nodes, is the second most common type of non-Hodgkin lymphoma. It occurs when white blood cells develop abnormally, increasing in number and growing in clumps called follicles. 

Globally there are hundreds of thousands of people living with this currently incurable cancer. There are around 2,000 people diagnosed with follicular lymphoma every year in the UK and 16,500 diagnosed every year in the US.

While outcomes for patients with FL have improved substantially over the last 40 years nearly all patients experience relapses, sometimes many times, over the course of their disease. A subset of patients – around 20% - will develop a fast-progressing form of the disease and face 5-year survival rates as low as 50%. All patients endure the psychological toll of an incurable, relapsing disease and the increasing levels of toxicity associated with the treatment options available as the disease continues to relapse. 

The Follicular Lymphoma Foundation have launched the FLF CURE FL Awards, managed and administered by the Milken Institute Center for Strategic Philanthropy, to advance research that will lead to a cure for FL and improve treatment options for those who live with FL today, and for anyone who might be diagnosed in the future. 

Please click HERE for the Request for Proposals, which outlines LOI and application requirements. If you have any questions or need assistance applying, please reach out to CUREFL@milkeninstitute.org.


Applicant Eligibility Criteria:

  • Each grant applicant may be an academic or research institution, non-profit organization, or for-profit company, and may be based in
    any country.
  • All proposed research projects must be led by a Principal Investigator (PI), or organizational equivalent, who holds a doctorate (e.g., Ph.D., M.D.) or related research doctorate degree.
  • Eligible organizations may submit more than one proposal, but each proposal must be led by a unique PI or organizational equivalent.
Apply

The Follicular Lymphoma Foundation (FLF) CURE FL Awards



The Follicular Lymphoma Foundation (FLF) CURE FL Awards

Curative Research to Eliminate Follicular Lymphoma

Letters of Intent due February 4, 2022 | Full Proposals due April 15, 2022


Follicular lymphoma, a blood cancer that affects the lymph nodes, is the second most common type of non-Hodgkin lymphoma. It occurs when white blood cells develop abnormally, increasing in number and growing in clumps called follicles. 

Globally there are hundreds of thousands of people living with this currently incurable cancer. There are around 2,000 people diagnosed with follicular lymphoma every year in the UK and 16,500 diagnosed every year in the US.

While outcomes for patients with FL have improved substantially over the last 40 years nearly all patients experience relapses, sometimes many times, over the course of their disease. A subset of patients – around 20% - will develop a fast-progressing form of the disease and face 5-year survival rates as low as 50%. All patients endure the psychological toll of an incurable, relapsing disease and the increasing levels of toxicity associated with the treatment options available as the disease continues to relapse. 

The Follicular Lymphoma Foundation have launched the FLF CURE FL Awards, managed and administered by the Milken Institute Center for Strategic Philanthropy, to advance research that will lead to a cure for FL and improve treatment options for those who live with FL today, and for anyone who might be diagnosed in the future. 

Please click HERE for the Request for Proposals, which outlines LOI and application requirements. If you have any questions or need assistance applying, please reach out to CUREFL@milkeninstitute.org.


Applicant Eligibility Criteria:

  • Each grant applicant may be an academic or research institution, non-profit organization, or for-profit company, and may be based in
    any country.
  • All proposed research projects must be led by a Principal Investigator (PI), or organizational equivalent, who holds a doctorate (e.g., Ph.D., M.D.) or related research doctorate degree.
  • Eligible organizations may submit more than one proposal, but each proposal must be led by a unique PI or organizational equivalent.
Apply
Open to
Organizations and individual applicants can apply.
Opens
Jan 10 2022 12:00 AM (EST)
Deadline
Apr 15 2022 11:59 PM (EDT)